# Anti-tuberculosis (TB) Drug Levels and Hepatotoxicity

> **NCT00929786** · — · COMPLETED · sponsor: **All India Institute of Medical Sciences** · enrollment: 72 (actual)

## Conditions studied

- Hepatitis
- Tuberculosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00929786
- **Lead sponsor:** All India Institute of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2009-04
- **Final completion:** 2009-06
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2009-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00929786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00929786, "Anti-tuberculosis (TB) Drug Levels and Hepatotoxicity". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00929786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*